Patent suit against Osteometer (Denmark) withdrawn:
This article was originally published in Clinica
Ostex International (US) has withdrawn legal action against Osteometer (Denmark) in the Netherlands in which it alleged patent infringement of technology incorporated in the bone resorption assay, Osteomark (see Clinica No 663, p 15). Osteometer is working with Cortecs on the development of a doctor's office test for osteoporosis using Osteometer's CrossLaps technology which was the subject of the legal action. Cortecs aims to launch the test this calendar year, says president Dr Michael Flynn.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.